Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07170111 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Predictors of GON Blockade Success in Migraine

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This multicenter, prospective cohort study aims to identify clinical and demographic predictors that influence the success of greater occipital nerve (GON) block in patients with migraine. Patients will be evaluated at baseline, on each injection day, and at one- and three-month follow-ups. Study parameters include demographics, migraine type and duration, comorbidities, headache characteristics, treatment history, and validated outcome measures such as the Numeric Rating Scale (NRS), Headache Impact Test-6 (HIT-6), and Global Rating of Change (GRoC). The goal is to establish predictive factors of treatment success in order to optimize patient selection and contribute robust multicenter evidence to individualized migraine management
Trial Details
NCT Number NCT07170111
Lead Sponsor Başakşehir Çam & Sakura City Hospital
Collaborators: Umraniye Education and Research Hospital, Gaziantep City Hospital, Namik Kemal University School of Medicine, Tekirdag, Bakırçay University, Faculty of Medicine
Conditions
(from sponsor)		 Migraine
Related terms Migraine Disorders
Enrollment 460 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov